Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advan... Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing. Mehr anzeigen
Agreement Expands Access to Pioneering Proteomics Technology Across the U.S. and Canadian Markets Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein...
Collaboration will Drive AI-Powered Advancements in Next-Generation Protein Sequencing™ and Accelerated Data Processing Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the...
Sets stage for advanced scientific discovery of new diagnostic biomarkers and treatments for disease Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein...
Combined Teams Aim to Deliver Novel Proteomics Platform in Under Two Years Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, and...
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Compensation Committee of Quantum-Si’s Board of Directors...
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it has been awarded Frost & Sullivan’s prestigious 2024...
Sales Pipeline is Accelerating and New Kits Remain on Track for Q4 Launch Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today...
Published Preprint Demonstrates Platinum’s Capability to Discriminate Peptide Variants with Single Amino Acid Resolution Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the...
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in two upcoming investment...
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Company will host an Investor & Analyst event in New...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.822181 | 103.040659516 | 0.797919 | 1.58 | 0.6121 | 1008308 | 0.70109268 | CS |
| 4 | 0.8244 | 103.606887018 | 0.7957 | 1.58 | 0.6121 | 732596 | 0.77629133 | CS |
| 12 | 0.6355 | 64.5439772496 | 0.9846 | 1.58 | 0.6121 | 535335 | 0.83995229 | CS |
| 26 | -0.1899 | -10.4917127072 | 1.81 | 1.84 | 0.6121 | 671511 | 0.9860655 | CS |
| 52 | -0.0299 | -1.81212121212 | 1.65 | 2.43 | 0.6121 | 683600 | 1.38499531 | CS |
| 156 | -5.9899 | -78.7109067017 | 7.61 | 8.44 | 0.6121 | 894991 | 2.72933035 | CS |
| 260 | -9.1299 | -84.9293023256 | 10.75 | 14.17 | 0.6121 | 919562 | 3.79472276 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
